查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930135

全球生物資訊服務市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測（2026-2034）

Bioinformatics Services Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 請詢問到貨日

價格

生物資訊服務市場成長因素

預計2025年全球生物資訊服務市場規模將達到65.1億美元，並從2026年的78.2億美元成長至2034年的220.3億美元，在預測期內維持13.83%的強勁複合年增長率。北美地區憑藉強大的研究基礎設施、大規模基因組計畫以及眾多主要服務提供者的存在，在2025年佔市場主導地位，市佔率高達45.87%。

生物資訊學是一門交叉學科，它融合了電腦科學、生物統計學和生命科學，用於分析和解讀海量的生物數據。 生物資訊學服務在基因組和蛋白質體學生物標記發現、藥物研發、疾病診斷和個人化醫療中發揮關鍵作用。這些服務在醫療保健、農業、法醫學、獸醫學和生物技術領域的日益廣泛應用，正在加速其在全球市場的滲透。

市場驅動因素

推動市場成長的關鍵因素之一是雲端生物資訊解決方案的日益普及，這些解決方案能夠降低營運成本並改善對大型臨床資料集的存取。各國政府和醫療機構正致力於採用這些解決方案，以加速研究工作流程並滿足日益增長的個人化醫療需求。

製藥和生物技術公司越來越多地將生物資訊服務外包，用於分析臨床試驗和藥物發現數據，這進一步推動了市場成長。基因組學、蛋白質組學和生物製藥研究領域的快速創新，正在推動對高階數據解讀服務的需求。

在新冠疫情期間，由於對病毒基因組數據分析的迫切需求，生物資訊服務市場經歷了強勁增長。各國政府和產業參與者為支持疫苗和治療藥物研發而增加的投資，顯著推動了這段時期的收入成長。

市場趨勢

影響市場發展的關鍵趨勢是生物資訊學在個人化醫療和疫苗研發領域的應用日益廣泛。先進的定序技術和分析工具能夠實現精準診斷、標靶治療，並改善治療效果，減少副作用。

生物資訊學正越來越多地應用於基因序列診斷、疾病風險預測、藥物發現和個人化疫苗策略。將人工智慧 (AI) 和機器學習整合到基因組數據分析中，進一步提高了研究效率，同時減少了臨床試驗的時間和成本。

限制因子

儘管成長前景強勁，但市場仍面臨著資料管理、標準化和倫理問題等方面的挑戰。 管理多樣化且複雜的生物資料集需要熟練的專業人員，而新興地區的此類人才供應有限。

在許多國家，基因組資料儲存、共享和隱私方面的倫理和法律問題仍未解決。此外，缺乏處理大型生物資料集的標準化指南，以及定序和資料儲存基礎設施需要不斷升級，可能會在一定程度上限制市場成長。

市場區隔分析

依服務類型劃分：

預計到2026年，定序服務將以37.72%的市佔率領先，這主要得益於次世代定序技術的廣泛應用和定序成本的下降。數據分析和藥物發現服務也佔了相當大的市場佔有率，因為它們在基因組學和藥物研究中發揮著重要作用。

依應用領域劃分：

到2026年，基因組學領域將佔全球市場佔有率的35.68%，這主要得益於基因組研究計畫和政府資助的增加。代謝組學和藥理學也貢獻顯著，而轉錄組學則提供了新的成長機會。

依最終使用者劃分：

到2026年，製藥和生物技術領域將繼續保持領先地位，市場佔有率將達到45.52%，這主要得益於廣泛的臨床研究活動以及生物資訊學在加速藥物發現方面的應用。 由於成本效益高且耗時短，合約研究組織 (CRO) 和研究機構也佔了相當大的市場佔有率。

區域洞察

  • 北美：在政府大力投資和完善的生物資訊基礎設施的支持下，預計到 2025 年，市場規模將達到 29.9 億美元。
  • 歐洲：由於基因組學研究經費的增加和個人化醫療的推動，預計市場將保持穩定成長。
  • 亞太地區：受臨床試驗活動增加的推動，預計亞太地區的複合年增長率 (CAGR) 將最高。預計到 2026 年，日本市場規模將達到 7.5 億美元，中國將達到 4.3 億美元，印度將達到 3.3 億美元。
  • 拉丁美洲、中東和非洲：由於基礎設施不足和普及率低，預計成長速度將較為緩慢。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 關鍵產業趨勢：併購、業務合作
  • 生物資訊科技進步
  • 新冠疫情對市場的影響

第五章 全球生物資訊服務市場分析：洞察與預測 （2021-2034）

  • 市場分析、洞察與預測：依服務類型劃分
    • 定序
    • 基因表達
    • 資料分析
    • 藥物發現
    • 其他
  • 市場分析、洞察與預測：依應用領域劃分
    • 代謝組學
    • 藥理學
    • 基因體學
    • 轉錄組學
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 製藥和生技公司
    • 合約研究組織 (CRO) 和研究機構
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲美洲
    • 中東和非洲

第六章 北美生物資訊服務市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲生物資訊服務市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家

第八章 亞太地區生物資訊服務市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 亞太其他地區

第九章：拉丁美洲生物資訊服務市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲生物資訊服務市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會（GCC）國家
    • 南非
    • 中東其他地區非洲

第11章 競爭分析

  • 世界市場佔有率分析(2025年)
  • 企業簡介
    • Illumina, Inc.
    • QIAGEN
    • CD Genomics
    • Excelra
    • Creative Proteomics
    • Fios Genomics.
    • Thermo Fisher Scientific Inc.
    • Eurofins Scientific
    • Psomagen
Product Code: FBI109496

Growth Factors of bioinformatics services Market

The global bioinformatics services market was valued at USD 6.51 billion in 2025 and is projected to grow from USD 7.82 billion in 2026 to USD 22.03 billion by 2034, registering a robust CAGR of 13.83% during the forecast period. North America dominated the market with a share of 45.87% in 2025, supported by strong research infrastructure, large-scale genomic initiatives, and the presence of major service providers.

Bioinformatics is an interdisciplinary field integrating computer science, biostatistics, and life sciences to analyze and interpret vast volumes of biological data. Bioinformatics services play a crucial role in genomic and proteomic biomarker discovery, drug development, disease diagnosis, and personalized medicine. The expanding application of these services across healthcare, agriculture, forensic science, veterinary science, and biotechnology is accelerating global market penetration.

Market Drivers

One of the primary growth drivers is the rising adoption of cloud-based bioinformatics solutions, which reduce operational costs and improve accessibility to large clinical datasets. Governments and healthcare organizations are increasingly focusing on implementing these solutions to accelerate research workflows and meet the growing demand for personalized medicine.

The increasing outsourcing of bioinformatics services by pharmaceutical and biotechnology companies to analyze clinical trial and drug discovery data has further boosted market growth. Rapid innovation in genomics, proteomics, and biopharmaceutical research is driving demand for advanced data interpretation services.

During the COVID-19 pandemic, the bioinformatics services market experienced positive growth due to the urgent need to analyze viral genomic data. Increased investments by governments and industry players to support vaccine and therapeutic development significantly contributed to revenue growth during this period.

Market Trends

A key trend shaping the market is the growing application of bioinformatics in personalized medicine and vaccine development. Advanced sequencing technologies and analytical tools enable precise diagnosis, targeted therapies, and improved treatment outcomes with reduced side effects.

Bioinformatics is increasingly used in gene sequencing diagnostics, disease risk prediction, drug discovery, and personalized vaccination strategies. The integration of artificial intelligence and machine learning into genomic data analysis is further enhancing research efficiency while reducing time and cost associated with clinical studies.

Restraining Factors

Despite strong growth prospects, the market faces challenges related to data management, standardization, and ethical concerns. Managing diverse and complex biological datasets requires skilled professionals, which are in limited supply in emerging regions.

Ethical and legal issues related to genomic data storage, sharing, and privacy remain unresolved in many countries. Additionally, the lack of standardized guidelines for handling large-scale biological datasets and the need for continuous upgrades in sequencing and data storage infrastructure may restrict market growth to some extent.

Segmentation Analysis

By Service Type:

The sequencing segment dominated the market with a share of 37.72% in 2026, driven by the widespread adoption of next-generation sequencing technologies and declining sequencing costs. Data analysis and drug discovery services also held substantial market shares due to their critical role in genomics and pharmaceutical research.

By Application:

The genomics segment accounted for 35.68% of the global market share in 2026, supported by increasing genomic research programs and government funding. Metabolomics and pharmacology also contributed significantly, while transcriptomics offers emerging growth opportunities.

By End User:

The pharmaceutical and biotechnology companies segment dominated with a 45.52% share in 2026, driven by extensive clinical research activities and the integration of bioinformatics to accelerate drug discovery. CROs and research institutes also held a significant share due to cost and time efficiency.

Regional Insights

  • North America: Generated USD 2.99 billion in 2025, supported by strong government investments and a well-established bioinformatics infrastructure.
  • Europe: Witnessed steady growth due to increasing genomics funding and personalized medicine initiatives.
  • Asia Pacific: Expected to grow at the highest CAGR, driven by rising clinical trial activity. By 2026, Japan is projected to reach USD 0.75 billion, China USD 0.43 billion, and India USD 0.33 billion.
  • Latin America & Middle East & Africa: Moderate growth due to limited infrastructure and lower adoption rates.

Competitive Landscape

Key players include Illumina, QIAGEN, Thermo Fisher Scientific, Eurofins Scientific, CD Genomics, and Excelra. These companies focus on strategic collaborations, acquisitions, and technological advancements to expand their service offerings and global presence.

Conclusion

The global bioinformatics services market is poised for significant growth from 2025 to 2034, driven by rising demand for genomic data analysis, personalized medicine, and drug discovery services. While challenges related to data management and ethical concerns persist, continuous technological advancements, strong government support, and expanding applications across healthcare and life sciences are expected to sustain market momentum. By 2034, the market is projected to reach USD 22.03 billion, reflecting the growing importance of bioinformatics services in modern biomedical research and healthcare innovation.

Segmentation By Service Type

  • Sequencing
  • Gene Expression
  • Data Analysis
  • Drug Discovery
  • Others

By Application

  • Metabolomics
  • Pharmacology
  • Genomics
  • Transcriptomics
  • Others

By End User

  • Pharmaceutical & Biotechnological Companies
  • CROs & Research Institutes
  • Others

By Region

  • North America (By Service Type, Application, End-User, By Country)
    • U.S.
    • Canada
  • Europe (By Service Type, Application, End-User, Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (By Service Type, Application, End-User, Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Service Type, Application, End-User, Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Service Type, Application, End-User, Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.2. Technological Advancement in Bioinformatics
  • 4.3. Impact of COVID-19 on the Market

5. Global Bioinformatics Services Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Service Type
    • 5.1.1. Sequencing
    • 5.1.2. Gene Expression
    • 5.1.3. Data Analysis
    • 5.1.4. Drug Discovery
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Metabolomics
    • 5.2.2. Pharmacology
    • 5.2.3. Genomics
    • 5.2.4. Transcriptomics
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Pharmaceutical & Biotechnological Companies
    • 5.3.2. CROs & Research Institutes
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Bioinformatics Services Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Service Type
    • 6.1.1. Sequencing
    • 6.1.2. Gene Expression
    • 6.1.3. Data Analysis
    • 6.1.4. Drug Discovery
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Metabolomics
    • 6.2.2. Pharmacology
    • 6.2.3. Genomics
    • 6.2.4. Transcriptomics
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Pharmaceutical & Biotechnological Companies
    • 6.3.2. CROs & Research Institutes
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Bioinformatics Services Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Service Type
    • 7.1.1. Sequencing
    • 7.1.2. Gene Expression
    • 7.1.3. Data Analysis
    • 7.1.4. Drug Discovery
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Metabolomics
    • 7.2.2. Pharmacology
    • 7.2.3. Genomics
    • 7.2.4. Transcriptomics
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Pharmaceutical & Biotechnological Companies
    • 7.3.2. CROs & Research Institutes
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Rest of Europe

8. Asia Pacific Bioinformatics Services Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Service Type
    • 8.1.1. Sequencing
    • 8.1.2. Gene Expression
    • 8.1.3. Data Analysis
    • 8.1.4. Drug Discovery
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Metabolomics
    • 8.2.2. Pharmacology
    • 8.2.3. Genomics
    • 8.2.4. Transcriptomics
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Pharmaceutical & Biotechnological Companies
    • 8.3.2. CROs & Research Institutes
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Rest of Asia Pacific

9. Latin America Bioinformatics Services Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Service Type
    • 9.1.1. Sequencing
    • 9.1.2. Gene Expression
    • 9.1.3. Data Analysis
    • 9.1.4. Drug Discovery
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Metabolomics
    • 9.2.2. Pharmacology
    • 9.2.3. Genomics
    • 9.2.4. Transcriptomics
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Pharmaceutical & Biotechnological Companies
    • 9.3.2. CROs & Research Institutes
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Bioinformatics Services Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Service Type
    • 10.1.1. Sequencing
    • 10.1.2. Gene Expression
    • 10.1.3. Data Analysis
    • 10.1.4. Drug Discovery
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Metabolomics
    • 10.2.2. Pharmacology
    • 10.2.3. Genomics
    • 10.2.4. Transcriptomics
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Pharmaceutical & Biotechnological Companies
    • 10.3.2. CROs & Research Institutes
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Illumina, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. QIAGEN
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. CD Genomics
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Excelra
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Creative Proteomics
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Fios Genomics.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Thermo Fisher Scientific Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Eurofins Scientific
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Psomagen
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Bioinformatics Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 2: Global Bioinformatics Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Bioinformatics Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 4: Global Bioinformatics Services Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Bioinformatics Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 6: North America Bioinformatics Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 7: North America Bioinformatics Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 8: North America Bioinformatics Services Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Bioinformatics Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 10: Europe Bioinformatics Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: Europe Bioinformatics Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 12: Europe Bioinformatics Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Bioinformatics Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 14: Asia Pacific Bioinformatics Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Asia Pacific Bioinformatics Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 16: Asia Pacific Bioinformatics Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Bioinformatics Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 18: Latin America Bioinformatics Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Latin America Bioinformatics Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 20: Latin America Bioinformatics Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Bioinformatics Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 22: Middle East & Africa Bioinformatics Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Middle East & Africa Bioinformatics Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 24: Middle East & Africa Bioinformatics Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Bioinformatics Services Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Bioinformatics Services Market Value Share (%), by Service Type, 2025 & 2034
  • Figure 3: Global Bioinformatics Services Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Bioinformatics Services Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Bioinformatics Services Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Bioinformatics Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 7: North America Bioinformatics Services Market Value Share (%), by Service Type, 2025
  • Figure 8: North America Bioinformatics Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Bioinformatics Services Market Value Share (%), by Application, 2025
  • Figure 10: North America Bioinformatics Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Bioinformatics Services Market Value Share (%), by End User, 2025
  • Figure 12: North America Bioinformatics Services Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Bioinformatics Services Market Value Share (%), By Country, 2025
  • Figure 14: Europe Bioinformatics Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 15: Europe Bioinformatics Services Market Value Share (%), by Service Type, 2025
  • Figure 16: Europe Bioinformatics Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Bioinformatics Services Market Value Share (%), by Application, 2025
  • Figure 18: Europe Bioinformatics Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Bioinformatics Services Market Value Share (%), by End User, 2025
  • Figure 20: Europe Bioinformatics Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Bioinformatics Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Bioinformatics Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 23: Asia Pacific Bioinformatics Services Market Value Share (%), by Service Type, 2025
  • Figure 24: Asia Pacific Bioinformatics Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Bioinformatics Services Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Bioinformatics Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Bioinformatics Services Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Bioinformatics Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Bioinformatics Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Bioinformatics Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 31: Latin America Bioinformatics Services Market Value Share (%), by Service Type, 2025
  • Figure 32: Latin America Bioinformatics Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Bioinformatics Services Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Bioinformatics Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Bioinformatics Services Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Bioinformatics Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Bioinformatics Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Bioinformatics Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 39: Middle East & Africa Bioinformatics Services Market Value Share (%), by Service Type, 2025
  • Figure 40: Middle East & Africa Bioinformatics Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Bioinformatics Services Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Bioinformatics Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Bioinformatics Services Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Bioinformatics Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Bioinformatics Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Bioinformatics Services Market Share (%), By Company, 2025